Report Detail

Other Global Narcolepsy Market Size, Status and Forecast 2019-2025

  • RnM2800158
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Other

Global Narcolepsy Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Narcolepsy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Type 1 Narcolepsy
      • 1.4.3 Type 2 Narcolepsy
    • 1.5 Market by Application
      • 1.5.1 Global Narcolepsy Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Retail Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Narcolepsy Market Size
    • 2.2 Narcolepsy Growth Trends by Regions
      • 2.2.1 Narcolepsy Market Size by Regions (2014-2025)
      • 2.2.2 Narcolepsy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Narcolepsy Market Size by Manufacturers
      • 3.1.1 Global Narcolepsy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Narcolepsy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Narcolepsy Key Players Head office and Area Served
    • 3.3 Key Players Narcolepsy Product/Solution/Service
    • 3.4 Date of Enter into Narcolepsy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Narcolepsy Market Size by Type (2014-2019)
    • 4.2 Global Narcolepsy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Narcolepsy Market Size (2014-2019)
    • 5.2 Narcolepsy Key Players in United States
    • 5.3 United States Narcolepsy Market Size by Type
    • 5.4 United States Narcolepsy Market Size by Application

    6 Europe

    • 6.1 Europe Narcolepsy Market Size (2014-2019)
    • 6.2 Narcolepsy Key Players in Europe
    • 6.3 Europe Narcolepsy Market Size by Type
    • 6.4 Europe Narcolepsy Market Size by Application

    7 China

    • 7.1 China Narcolepsy Market Size (2014-2019)
    • 7.2 Narcolepsy Key Players in China
    • 7.3 China Narcolepsy Market Size by Type
    • 7.4 China Narcolepsy Market Size by Application

    8 Japan

    • 8.1 Japan Narcolepsy Market Size (2014-2019)
    • 8.2 Narcolepsy Key Players in Japan
    • 8.3 Japan Narcolepsy Market Size by Type
    • 8.4 Japan Narcolepsy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Narcolepsy Market Size (2014-2019)
    • 9.2 Narcolepsy Key Players in Southeast Asia
    • 9.3 Southeast Asia Narcolepsy Market Size by Type
    • 9.4 Southeast Asia Narcolepsy Market Size by Application

    10 India

    • 10.1 India Narcolepsy Market Size (2014-2019)
    • 10.2 Narcolepsy Key Players in India
    • 10.3 India Narcolepsy Market Size by Type
    • 10.4 India Narcolepsy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Narcolepsy Market Size (2014-2019)
    • 11.2 Narcolepsy Key Players in Central & South America
    • 11.3 Central & South America Narcolepsy Market Size by Type
    • 11.4 Central & South America Narcolepsy Market Size by Application

    12 International Players Profiles

    • 12.1 Jazz Pharmaceuticals
      • 12.1.1 Jazz Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Narcolepsy Introduction
      • 12.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)
      • 12.1.5 Jazz Pharmaceuticals Recent Development
    • 12.2 Bioprojet
      • 12.2.1 Bioprojet Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Narcolepsy Introduction
      • 12.2.4 Bioprojet Revenue in Narcolepsy Business (2014-2019)
      • 12.2.5 Bioprojet Recent Development
    • 12.3 Arena Pharmaceuticals
      • 12.3.1 Arena Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Narcolepsy Introduction
      • 12.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)
      • 12.3.5 Arena Pharmaceuticals Recent Development
    • 12.4 Graymark Healthcare
      • 12.4.1 Graymark Healthcare Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Narcolepsy Introduction
      • 12.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2014-2019)
      • 12.4.5 Graymark Healthcare Recent Development
    • 12.5 Mylan
      • 12.5.1 Mylan Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Narcolepsy Introduction
      • 12.5.4 Mylan Revenue in Narcolepsy Business (2014-2019)
      • 12.5.5 Mylan Recent Development
    • 12.6 Teva Pharmaceutical Industries
      • 12.6.1 Teva Pharmaceutical Industries Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Narcolepsy Introduction
      • 12.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2014-2019)
      • 12.6.5 Teva Pharmaceutical Industries Recent Development
    • 12.7 Novartis
      • 12.7.1 Novartis Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Narcolepsy Introduction
      • 12.7.4 Novartis Revenue in Narcolepsy Business (2014-2019)
      • 12.7.5 Novartis Recent Development
    • 12.8 Shire
      • 12.8.1 Shire Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Narcolepsy Introduction
      • 12.8.4 Shire Revenue in Narcolepsy Business (2014-2019)
      • 12.8.5 Shire Recent Development
    • 12.9 Shionogi
      • 12.9.1 Shionogi Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Narcolepsy Introduction
      • 12.9.4 Shionogi Revenue in Narcolepsy Business (2014-2019)
      • 12.9.5 Shionogi Recent Development
    • 12.10 Ligand Pharmaceuticals
      • 12.10.1 Ligand Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Narcolepsy Introduction
      • 12.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)
      • 12.10.5 Ligand Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
      People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
      In 2018, the global Narcolepsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Narcolepsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Narcolepsy development in United States, Europe and China.

      The key players covered in this study
      Jazz Pharmaceuticals
      Bioprojet
      Arena Pharmaceuticals
      Graymark Healthcare
      Mylan
      Teva Pharmaceutical Industries
      Novartis
      Shire
      Shionogi
      Ligand Pharmaceuticals

      Market segment by Type, the product can be split into
      Type 1 Narcolepsy
      Type 2 Narcolepsy

      Market segment by Application, split into
      Hospitals
      Clinics
      Retail Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Narcolepsy status, future forecast, growth opportunity, key market and key players.
      To present the Narcolepsy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Narcolepsy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Narcolepsy . Industry analysis & Market Report on Narcolepsy is a syndicated market report, published as Global Narcolepsy Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Narcolepsy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,137.42
      4,706.13
      6,274.83
      3,474.24
      5,211.36
      6,948.48
      421,777.20
      632,665.80
      843,554.40
      268,194.03
      402,291.05
      536,388.06
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report